PharmaSynergy-Rx

5&6th February 2026, London, United Kingdom


Day One, 5th February

Moderator: Tobias Handschuh, Partner, EU Markets Leader Strategic Advisory,
Trinity Life Sciences

Analytical Outlook: Aurelio Arias, Director, Thought Leadership, IQVIA
Title: Finding Growth in Tomorrow’s Off-Patent Industry
 
Discussion on Portfolio and Strategy: Value, Focus, Scale – Exploring specialisation, organic growth, and core therapeutic franchises; expanding across regions to avoid concentration; driving growth through diversification, consolidation, M&A, and in-licensing; and phasing out legacy strategies and products.
Alberto Escobar, Head of Partner Markets – International, CNX Therapeutics
Kiren Naidoo, Chief Executive Officer, Frontier Pharma, Zdravlje
Joerg Serafimov, Chief Business Officer, AMW GmbH

Company Spotlights

Dhaval Soneji, Director, Global Key Accounts, International Business Affairs, Gan & Lee Pharmaceuticals
Title: Recent trends in Business Development and Gan & Lee’s Strategic move from Biosimilar to Novel Biologics

In Gyu Kim, General Manager/Global Alliance & Planning, G2GBIO 
Title: InnoLAMP™: A Scalable Microsphere Platform for Next-Generation
Long-Acting Injectables


Fiona Li Ningfeng, Founder & CEO, VasoDynamics
Title: A Patient-Friendly Approach to Improved Cancer Care

Technology Platforms for Growth, BD & Licensing

Anna Torrents,
 Co-founder, Metly
Title: Powering Enterprise Strategy With AI-Native Knowledge Integration

Mindaugas Zagorskis, Founder & CEO, Pipelinepharma
Title: Pipeline Intelligence and Product Sourcing Platforms


Day Two, 6th February

Moderator: Adam Barak, Founder & Managing Director, PPi Healthcare Consulting
Title: International Market Access – Overview

Bobby George, VP, Group Head Regulatory Affairs, Reliance Life Sciences
Title: Spotlight on Biosimilars 

Stefanie Fasshauer, Director of Business Development, Cisema
Title: China: Understanding the System Behind the Market

Mohamed Saad, Commercial Development Manager, Avalon Pharmaceuticals & Founder, Emerging Pharma Intelligence Platform
Title: MENA as the Next Pharma Scale Platform: From Capital Inflows to Execution Reality

Adriana Hernandez, COO of Udelá Global
Title: Regulatory Outlook on Latin America